Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease
What This Means
Angelini Pharma to Acquire Catalyst Pharmaceuticals for 4.1 Billion USD (3.5 Billion Euros), Entering the U.S. Market and Consolidating its Leadership in Brain Health and Rare Disease is scheduled for Thursday, May 7, 2026. High-impact macro releases like this can move SPX 0.5–2%+ in either direction — consider reducing Iron Condor position size or widening wings 1–2 days before release.
Ms Vixxy's Take
Ms Vixxy hasn't covered this event yet. Flash reports are generated automatically for high-impact events when they release — check back after the event date.
Why This Matters for Iron Condor Traders
High-impact macro events like Angelini Pharma to Acquire create volatility spikes that directly affect Iron Condor implied volatility and wing pricing. Understanding the release pattern — beat vs. miss — helps you set appropriate wing widths and entry timing.